New England Capital Financial Advisors »

Mereo Biopharma Group Plc ads shares owned by New England Capital Financial Advisors

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by New England Capital Financial Advisors from 13F filings

Historical chart of New England Capital Financial Advisors investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by New England Capital Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by New England Capital Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $990 300 3.30
2023-12-31 $693 300 2.31
2023-09-30 $387 300 1.29
2023-06-30 $396 300 1.32
2023-03-31 $213 300 0.71
2022-12-31 $291 300 0.97

More positions owned by New England Capital Financial Advisors

Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Capital Grp Fixed Incm Etf T Municipal Income (CGMU)
Spdr Ser Tr Bloomberg Invt (FLRN)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)

View all positions for New England Capital Financial Advisors

Top funds holding Mereo Biopharma Group Plc ads

Rubric Capital Management
Adage Capital Partners GP
Mangrove Partners
Rock Springs Capital Management
683 Capital Management
Henderson Group
Suvretta Capital Management
Clearline Capital
Soleus Capital Management
Tejara Capital
Goldman Sachs Group
Millennium Management
Susquehanna International
Morgan Stanley
T. Rowe Price Associates

View all funds holding Mereo Biopharma Group Plc ads